Updated: Dec 2025
85%
Employees say this is a great place to work
The origins of Daiichi Sankyo in Switzerland date back to 1998. Since 2022, the company has been under the management of Guiseppe Giulio Grossi and operates as an organization with over 50 employees.
The main focus of Daiichi Sankyo (Schweiz) AG is on the distribution of cardiovascular and oncological drugs.
A promising pipeline of innovative applications is aimed at various fields of application.
(Zurich)
Certification November 2025
Certification November 2024
Certification November 2025
Certification November 2024
English 
Deutsch 
Français 